Hjem › Brystkreft › Arkansas

Kliniske studier for Brystkreft i Arkansas

17 studier for Brystkreft søker deltakere på steder i Arkansas.

Byer i Arkansas

Offisiell studietekst (engelsk)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

CARTI Cancer Center, Little Rock

RekruttererFase 3

Alder 18 til 100 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Hospital Fort Smith, Fort Smith
CARTI Cancer Center, Little Rock

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen

Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Springdale

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06103864

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Hot Springs

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Genesis Cancer and Blood Institute, Hot Springs
Highlands Oncology Group, Springdale

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07174336

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Highlands Oncology Group, Springdale

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Highlands Oncology Group, PA, Springdale

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Genesis Cancer and Blood Institute, Hot Springs

RekruttererFase 1

Alder 18 til 55 · Kvinner · Oppdatert 9. sep. 2026 · NCT07310420

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Mercy Hospital Fort Smith, Fort Smith
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Baptist Health Medical Center - Little Rock, Little Rock
og 2 flere

RekruttererFase 3

Alder 18 til 60 · Kvinner · Oppdatert 2. sep. 2026 · NCT05879926

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

University of Arkansas for Medical Sciences, Little Rock

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06500481

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Local Institution - 0303, Hot Springs

RekruttererFase 2/3

Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06926868

E-Mindfulness Approaches for Living After Breast Cancer

Mercy Hospital Fort Smith, Fort Smith
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
University of Arkansas for Medical Sciences, Little Rock

RekruttererFase 3

Alder 18 til 50 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06748222